Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02551991 |
|---|---|
| Brief Title: | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma |
| First Submitted : | September 10, 2015 |
| First Submitted that Met QC Criteria : | September 15, 2015 |
| First Posted : | September 16, 2015 (Estimate) |
| Results First Submitted : | May 20, 2022 |
| Results First Submitted that Met QC Criteria : | October 7, 2022 |
| Results First Posted : | October 10, 2022 |
| Last Update Submitted that Met QC Criteria : | October 7, 2022 |
| Last Update Posted : | October 10, 2022 |